| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |